Neoprospecta Overview

  • Founded
  • 2011
  • Status
  • Private
  • Employees
  • 51
  • Latest Deal Type
  • 2ndary - Private
  • Investors
  • 2

Neoprospecta General Information


Developer of a biotechnology platform designed to deal with microbiological analysis, management and control. The company's platform offers innovative microbiological analyzes, biocomputational analysis and quantitative PCR techniques which has created a line of rapid tests for the detection of microorganisms and antibiotic resistance genes, enabling biotechnology firms to identify microorganisms using new DNA sequencing technologies

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Primary Industry
Other Industries
Other Pharmaceuticals and Biotechnology
Primary Office
  • Av. Luiz Boiteux Piazza, 1302 - InovaLab
  • Cachoeira do Bom Jesus Sapiens Parque
  • Florianópolis, 88056
  • Brazil
+55 (48) 0000-0000
Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

Neoprospecta Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
3. Secondary Transaction - Private 01-Feb-2021 00.000 Completed Generating Revenue
2. Early Stage VC 08-Aug-2014 00.000 00.000 Completed Generating Revenue
1. Early Stage VC 15-Feb-2013 $249K $249K Completed Generating Revenue
To view Neoprospecta’s complete valuation and funding history, request access »

Neoprospecta Executive Team (5)

Name Title Board Seat Contact Info
Luiz Fernando Valter de Oliveira Co-Founder & Chief Executive Officer
Pedro Stadnik Controller
Luiz Felipe Valter de Oliveira Ph.D Co-Founder & Board Member
Ronaldo Mota Co-Founder
You’re viewing 4 of 5 executive team members. Get the full list »

Neoprospecta Board Members (1)

Name Representing Role Since
Luiz Felipe Valter de Oliveira Ph.D Neoprospecta Co-Founder & Board Member 000 0000
To view Neoprospecta’s complete board members history, request access »

Neoprospecta Signals

Growth Rate

0.80% Weekly
Weekly Growth 0.80%, 93rd %ile
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers


Similarweb Unique Visitors


Majestic Referring Domains


PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Neoprospecta Investors (2)

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info
CVentures Venture Capital Minority 000 0000 000000 0
Felipe Marcondes de Mattos Angel (individual) Minority 000 0000 000000 0
To view Neoprospecta’s complete investors history, request access »